761386-09-8

Basic information

• Product Name: Cyclohexanecarboxylic acid, 3-amino-, methyl ester, (1R,3S)-rel-(+)- (9CI)
• Synonyms: Cyclohexanecarboxylic acid, 3-amino-, methyl ester, (1R,3S)-rel-(+)- (9CI);methyl (1S,3R)-3-aminocyclohexane-1-carboxylate
• CAS NO: 761386-09-8
• Molecular Formula: C8H15NO2
• Molecular Weight: 157.2102
• Product Categories: CARBOXYLICESTER
• Mol File: 761386-09-8.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Cyclohexanecarboxylic acid, 3-amino-, methyl ester, (1R,3S)-rel-(+)- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanecarboxylic acid, 3-amino-, methyl ester, (1R,3S)-rel-(+)- (9CI)(761386-09-8)
• EPA Substance Registry System: Cyclohexanecarboxylic acid, 3-amino-, methyl ester, (1R,3S)-rel-(+)- (9CI)(761386-09-8)

Safety Data

• Hazardous Substances Data: 761386-09-8(Hazardous Substances Data)

Upstream product

• 930596-35-3 (1S,3R)-methyl 3-(tert-butoxycarbonylamino)cyclohexanecarboxylate 
• 222530-34-9 (1S,3R)-3-((tert-butoxycarbonyl)amino)cyclo hexane-1-carboxylic acid 
• 67-56-1 methanol 
• 218772-92-0 racemic trans-3-((tert-butoxycarbonyl)amino)cyclohexane-1-carboxylic acid 
• 16636-51-4 (+/-)-cis-3-aminocyclohexanecarboxylic acid 
• 849410-73-7 methyl 3-[(tert-butoxycarbonyl)amino]cyclohexanecarboxylate 
• 41235-88-5 trans-3-aminocyclohexane-1-carboxylic acid 
• 41235-88-5 cis-3-aminocyclohexanecarboxylic acid 
• 81131-40-0 (1S,3R)-3-aminocyclohexanecarboxylic acid 
• 16636-51-4 3-aminocyclohexanecarboxylic acid 

Downstream Products

• 721428-25-7 4-(tert-butyl-diphenyl-silanyloxy)-3-[(3-methoxycarbonyl-cyclohexylamino)-methyl]-indazole-1-carboxylic acid tert-butyl ester 

Relevant articles and documents

Asymmetric Synthesis of N-Substituted γ-Amino Esters and γ-Lactams Containing α,γ-Stereogenic Centers via a Stereoselective Enzymatic Cascade

γ-Amino esters and γ-lactams containing α,γ-stereogenic centers are widely used as chiral intermediates in various bioactive compounds, while their efficient synthesis remains a challenge. Herein, an enzymatic cascade reaction involving an ene reductase (

Pyrimidopyrazole compound, preparation method and application thereof

The invention discloses a pyrimidopyrazole compound, a preparation method and application thereof. The invention provides a pyrimidopyrazole compound shown as formula I or pharmaceutically acceptablesalts thereof. The compound has a relatively good inhibition effect on CDK7.

INDAZOLE DERIVATIVES USEFUL AS ERK INHIBITORS

The present invention provides a compound of the Formula I, or a pharmaceutically acceptable salt, solvate or ester thereof, wherein R, R1, R2, R3, m and are as defined herein. The compounds are ERK inhibitors. Also disclosed are pharmaceutical compositions that comprise the above compounds, and methods of treating cancer using the same.